Standard Biotools (LAB) Return on Assets (2016 - 2025)
Standard Biotools (LAB) has disclosed Return on Assets for 15 consecutive years, with 0.21% as the latest value for Q3 2025.
- On a quarterly basis, Return on Assets fell 14.0% to 0.21% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.21%, a 14.0% decrease, with the full-year FY2024 number at 0.3%, down 18.0% from a year prior.
- Return on Assets was 0.21% for Q3 2025 at Standard Biotools, down from 0.2% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.28% in Q3 2023 to a low of 0.46% in Q2 2022.
- A 5-year average of 0.14% and a median of 0.19% in 2024 define the central range for Return on Assets.
- Peak YoY movement for Return on Assets: skyrocketed 70bps in 2023, then plummeted -35bps in 2024.
- Standard Biotools' Return on Assets stood at 0.21% in 2021, then surged by 81bps to 0.04% in 2022, then plummeted by -212bps to 0.12% in 2023, then plummeted by -52bps to 0.19% in 2024, then fell by -9bps to 0.21% in 2025.
- Per Business Quant, the three most recent readings for LAB's Return on Assets are 0.21% (Q3 2025), 0.2% (Q2 2025), and 0.21% (Q1 2025).